Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yelena Y Janjigian

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?Yelena Y Janjigian
Cancer|February 18, 2022
Top advances in esophageal/gastroesophageal junction cancers in 2021Darren Cowzer, Yelena Y Janjigian
Thoracic Surgery Clinics|October 20, 2022
Immune Checkpoint Blockade and Targeted Therapies in Esophageal CancerJessica Yang, Yelena Y Janjigian
Nature Reviews. Clinical Oncology|March 2, 2016
Clinical impact of tumour biology in the management of gastroesophageal cancerFlorian Lordick, Yelena Y Janjigian
Cancer|January 23, 2019
Application of positron emission tomography imaging to personalize esophagogastric cancer careSebastian Mondaca, Yelena Y Janjigian
Journal of Surgical Oncology|October 9, 2012
Genomic dysregulation in gastric tumorsYelena Y Janjigian, David P Kelsen
Surgical Oncology Clinics of North America|March 11, 2017
Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric CancerYelena Y Janjigian, Maria Ignez Braghiroli
Nature Reviews. Gastroenterology & Hepatology|December 18, 2025
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targetsOrla M Fitzpatrick, Yelena Y Janjigian
Nature Clinical Practice. Oncology|October 24, 2007
Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment?Yelena Y Janjigian, Vincent A Miller
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking BarriersSamuel L Cytryn, Yelena Y Janjigian
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?Yelena Y Janjigian
Cancer|February 18, 2022
Top advances in esophageal/gastroesophageal junction cancers in 2021Darren Cowzer, Yelena Y Janjigian
Thoracic Surgery Clinics|October 20, 2022
Immune Checkpoint Blockade and Targeted Therapies in Esophageal CancerJessica Yang, Yelena Y Janjigian
Nature Reviews. Clinical Oncology|March 2, 2016
Clinical impact of tumour biology in the management of gastroesophageal cancerFlorian Lordick, Yelena Y Janjigian
Cancer|January 23, 2019
Application of positron emission tomography imaging to personalize esophagogastric cancer careSebastian Mondaca, Yelena Y Janjigian
Journal of Surgical Oncology|October 9, 2012
Genomic dysregulation in gastric tumorsYelena Y Janjigian, David P Kelsen
Surgical Oncology Clinics of North America|March 11, 2017
Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric CancerYelena Y Janjigian, Maria Ignez Braghiroli
Nature Reviews. Gastroenterology & Hepatology|December 18, 2025
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targetsOrla M Fitzpatrick, Yelena Y Janjigian
Nature Clinical Practice. Oncology|October 24, 2007
Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment?Yelena Y Janjigian, Vincent A Miller
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking BarriersSamuel L Cytryn, Yelena Y Janjigian
Pageof 17